APA (7th ed.) Citation

Katarzyna Kotfis, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, . . . Miłosz Parczewski. (2021). COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection. MDPI AG.

Chicago Style (17th ed.) Citation

Katarzyna Kotfis, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, Jowita Biernawska, Magda Wiśniewska, and Miłosz Parczewski. COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-CoV-2 Infection. MDPI AG, 2021.

MLA (9th ed.) Citation

Katarzyna Kotfis, et al. COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-CoV-2 Infection. MDPI AG, 2021.